Assyro AI
US FDAUnited StatesCRLComplete Response Letter

Complete Response Letter NDA 505b1 218524 (Mar 29, 2024)

Issued March 29, 2024

Issued

March 29, 2024

Application

NDA 505b1 • 218524

Review center

CDER

Stage

Final Decision

Letter type

Complete Response Letter

Response due March 29, 2025Requires resubmission addressing deficiencies.

Document viewer

Read the FDA letter and send context to the co-pilot at any time.

Loading PDF…